[Double-blind studies of the therapeutic action of S-Adenosylmethionine (SAMe) in oral administration, in liver cirrhosis and other chronic hepatitides].
Six oral administrations per day of 30 mg S-adenosylmethionine (SAMe) for 30 days, in addition to 6000 gamma/day of Vitamine B12 induced marked improvements of biochemical parameters in 20 patients with hepatic cirrhosis or various chronic hepatites. Particularly, the protidemia, bilirubinemia and radial immunodiffusion have shown the highest favorable drug responses. These improvements were still lasting and even further increasing 30 days after the end of therapy. In another group of patients with similar diagnosis and under clinical conditions comparable to the previous group of twenty, the administration of Vitamine B12 alone, in the same doses as above, has not induced any alteration in the biochemical parameters.
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008111:Liver Function Tests; D012436:S-Adenosylmethionine / Q000008:administration & dosage / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use
D012436:S-Adenosylmethionine; D014805:Vitamin B 12
Sperimentazione in doppio cieco sull'attività terapeutica della SAMe, somministrata per os, nelle cirrosi epatiche ed in altre epatiti croniche